Home>Topics>Companies>Johnson & Johnson

Johnson & Johnson JNJ

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. UPDATE 2-FDA expands use of Imbruvica to treat rare form of blood cancer

      Headlines

      Thu, 29 Jan 2015

      Jan 29 (Reuters) - The U.S. Food and Drug Administration approved the expanded use of Imbruvica, sold by Johnson & Johnson and Pharmacyclics Inc, to treat Waldenström's macroglobulinemia (WM), a rare form of blood cancer for which

    2. Plaintiffs' lawyers reject J & J claims of fraud in mesh lawsuits

      Headlines

      Fri, 23 Jan 2015

      NEW YORK, Jan 23 (Reuters) - Lawyers for thousands of women suing Johnson & Johnson 's Ethicon Inc over transvaginal mesh devices are fighting back against the company's claim that illegal phone solicitations may have resulted in baseless lawsuits.

    3. Morningstar's Most Popular

      Headlines

      Fri, 23 Jan 2015

      Most Requested Stock Quotes IBM Apple ExxonMobil Chevron GE Most Requested Stock Analyses IBM Priceline Schlumberger Johnson & Johnson Core Labs Most Requested Fund Quotes Vanguard Dividend Growth Vanguard 500 Index Dodge & Cox International Stock

    4. Johnson & Johnson's $7.2 billion claim against Boston Scientific now with U.S. judge

      Headlines

      Wed, 21 Jan 2015

      NEW YORK (Reuters) - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial – and ultimately ill-fated – bidding war for device maker Guidant.

    5. J & J's $7.2 bln claim against Boston Scientific now with U.S. judge

      Headlines

      Wed, 21 Jan 2015

      NEW YORK, Jan 21 (Reuters) - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.

    6. Johnson & Johnson's forex warning a sign for rival drugmakers

      Headlines

      Tue, 20 Jan 2015

      Jan 20 (Reuters) - Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating...

    7. BRIEF- J & J says 2015 analyst forecasts don't fully reflect negative foreign exchange trend

      Headlines

      Tue, 20 Jan 2015

      Jan 20 (Reuters) - Johnson & Johnson : * J & j CFO says negative foreign exchange trends hurt company 2015

    8. Stronger dollar hurts J & J's quarterly sales

      Headlines

      Tue, 20 Jan 2015

      (Reuters) - Johnson & Johnson reported lower-than-expected quarterly sales as a stronger dollar offset higher sales of the Band-Aid maker's new drugs and older treatments.

    9. UPDATE 1-Stronger dollar hurts J & J's quarterly sales

      Headlines

      Tue, 20 Jan 2015

      Jan 20 (Reuters) - Johnson & Johnson reported lower-than-expected quarterly sales as a stronger dollar offset higher sales of the Band-Aid maker's new drugs and older treatments.

    10. J & J's profit beats estimates on sales of new drugs

      Headlines

      Tue, 20 Jan 2015

      Jan 20 (Reuters) - Johnson & Johnson reported a slightly better-than-expected quarterly profit as surging sales of new drugs and mainstay older brands offset weak demand for medical devices and consumer healthcare products.

    « Prev12345Next »
    Content Partners